Ramona Sequeira has been selected to become president of the US Business Unit of Takeda Pharmaceuticals USA, the wholly-owned subsidiary of Japan-basedTakeda Pharmaceutical Company Limited.

As president Saqueira will head all business operations for the US. He will workd directly under Christophe Weber, President and CEO of Takeda.

“The U.S. is a critical market for Takeda’s future growth, and I am confident that with her strong commercial experience and knowledge of the U.S. healthcare environment, Ramona is the right person to lead this important business unit and play a key role on my

leadership team,” said Weber. “Her more than 20 years of leadership experience and track record of success across multiple healthcare markets, as well as her demonstrated passion for patient centricity, will serve as a critical foundation during Takeda’s global transformation.”

Sequeira was previously Vice President of Lilly USA at Eli Lilly and Company as well as the General manger of Lilly’s UK Hub. She is experienced in a wide range of therapeutic disciplines including neuroscience and primary care. She has experience working in the US, Canada and the UK.